November 20, 2023, Agios Pharmaceuticals Inc (NASDAQ: AGIO) trading session started at the price of $22.24, that was -3.41% drop from the session before. During the day, the shares moved up to $22.72 and dropped to $21.40 before settling in for the closing price of $22.26. A 52-week range for AGIO has been $19.80 – $31.87.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 8.87%. When this article was written, the company’s average yearly earnings per share was at -47.28%. With a float of $53.30 million, this company’s outstanding shares have now reached $55.04 million.
The extent of productivity of a business whose workforce counts for 389 workers is very important to gauge. In terms of profitability, gross margin is -42.30, operating margin of -2732.07, and the pretax margin is -1627.82.
Agios Pharmaceuticals Inc (AGIO) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Agios Pharmaceuticals Inc stocks. The insider ownership of Agios Pharmaceuticals Inc is 4.64%, while institutional ownership is 100.49%. The most recent insider transaction that took place on Sep 28, was worth 54,017. In this transaction Chief Financial Officer of this company sold 2,179 shares at a rate of $24.79, taking the stock ownership to the 9,575 shares. Before that another transaction happened on Aug 17, when Company’s Chief Legal Officer sold 6,395 for $26.28, making the entire transaction worth $168,061. This insider now owns 23,890 shares in total.
Agios Pharmaceuticals Inc (AGIO) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 9/29/2023, it has been observed that the corporation posted -$1.64 earnings per share (EPS) during the time that was better than consensus figure (set at -$1.7) by $0.06. This company achieved a net margin of -1627.82 while generating a return on equity of -19.37. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.56 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -47.28% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 39.00% during the next five years compared to 8.92% growth over the previous five years of trading.
Agios Pharmaceuticals Inc (NASDAQ: AGIO) Trading Performance Indicators
You can see what Agios Pharmaceuticals Inc (AGIO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 11.76. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 50.01.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.95, a number that is poised to hit -1.62 in the next quarter and is forecasted to reach -6.34 in one year’s time.
Technical Analysis of Agios Pharmaceuticals Inc (AGIO)
The latest stats from [Agios Pharmaceuticals Inc, AGIO] show that its last 5-days average volume of 0.48 million was inferior to 0.49 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 54.03%. Additionally, its Average True Range was 1.03.
During the past 100 days, Agios Pharmaceuticals Inc’s (AGIO) raw stochastic average was set at 19.16%, which indicates a significant decrease from 36.91% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 49.47% in the past 14 days, which was higher than the 34.42% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $23.10, while its 200-day Moving Average is $24.91. Now, the first resistance to watch is $22.35. This is followed by the second major resistance level at $23.19. The third major resistance level sits at $23.67. If the price goes on to break the first support level at $21.03, it is likely to go to the next support level at $20.55. Assuming the price breaks the second support level, the third support level stands at $19.71.
Agios Pharmaceuticals Inc (NASDAQ: AGIO) Key Stats
There are 55,891K outstanding shares of the company, which has a market capitalization of 1.20 billion. As of now, sales total 14,240 K while income totals -231,800 K. Its latest quarter income was 7,400 K while its last quarter net income were -91,320 K.